Spire Wealth Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-143	Closed	-$11.7K	–	2398
2025 Q4	$11.7K	Sell	143 -84	-37%	-$6.27K	﹤0.01%	1659
2025 Q3	$13.5K	Hold	227	–	–	﹤0.01%	1646
2025 Q2	$9.2K	Sell	227 -146	-39%	-$6.57K	﹤0.01%	1747
2025 Q1	$19.2K	Buy	373 +230	+161%	+$11.4K	﹤0.01%	1625
2024 Q4	$7.92K	Sell	143 -84	-37%	-$3.81K	﹤0.01%	1906
2024 Q3	$7.47K	Sell	227 -33	-13%	-$928	﹤0.01%	1722
2024 Q2	$7.07K	Buy	260 +127	+95%	+$4.27K	﹤0.01%	1742
2024 Q1	$4.83K	Buy	133 +67	+102%	+$1.97K	﹤0.01%	1936
2023 Q4	$1.55K	Sell	66 -80	-55%	-$1.34K	﹤0.01%	2193
2023 Q3	$2.59K	Hold	146	–	–	﹤0.01%	2076
2023 Q2	$2.64K	Buy	146 +43	+42%	+$684	﹤0.01%	2146
2023 Q1	$1.29K	Buy	+103	New	+$1.51K	﹤0.01%	2356
2022 Q3	–	Sell	-50	Closed	-$1K	–	2570
2022 Q2	$1K	Sell	50 -50	-50%	-$751	﹤0.01%	2579
2022 Q1	$2K	Hold	100	–	–	﹤0.01%	2420
2021 Q4	$2K	Hold	100	–	–	﹤0.01%	2802
2021 Q3	$2K	Hold	100	–	–	﹤0.01%	2486
2021 Q2	$3K	Hold	100	–	–	﹤0.01%	2436
2021 Q1	$3K	Buy	+100	New	+$3.7K	﹤0.01%	2777